These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37361978)

  • 1. Vector configuration screening failure after defibrillation threshold testing: Should we be concerned?
    Uzunoglu EC; Liu K; Adrover P; Suryanarayana PG; Elayi CS; Catanzaro JN
    HeartRhythm Case Rep; 2023 Jun; 9(6):401-405. PubMed ID: 37361978
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold.
    Kühlkamp V; Dörnberger V; Khalighi K; Mewis C; Suchalla R; Ziemer G; Seipel L
    Pacing Clin Electrophysiol; 1998 Dec; 21(12):2596-605. PubMed ID: 9894650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvenous-subcutaneous defibrillation leads: effect of transvenous electrode polarity on defibrillation threshold.
    Block M; Hammel D; Böcker D; Borggrefe M; Budde T; Isbruch F; Scheld HH; Breithardt G
    J Cardiovasc Electrophysiol; 1994 Nov; 5(11):912-8. PubMed ID: 7889231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Defibrillation Testing, Why Not?" survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice.
    Migliore F; Viani S; Ziacchi M; Ottaviano L; Francia P; Bianchi V; De Bonis S; De Filippo P; Tola G; Vicentini A; Taravelli E; Calvi VI; Lovecchio M; Valsecchi S; Botto GL;
    Int J Cardiol Heart Vasc; 2022 Feb; 38():100952. PubMed ID: 35071727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of shock therapy related to improper sensing of noise on the defibrillation test during subcutaneous implantable cardioverter-defibrillator implantation: a case report.
    Tamura S; Yoshiyama T; Doi A; Yoshiyama M
    Eur Heart J Case Rep; 2020 Dec; 4(6):1-6. PubMed ID: 33447710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous ICD implantation in a patient with hypertrophic cardiomyopathy after transvenous ICD failure: A case report.
    Baroni M; Cattafi G; Arupi M; Paolucci M; Pelenghi S; Lunati M
    J Arrhythm; 2018 Feb; 34(1):81-83. PubMed ID: 29721119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients.
    Lieberman R; Havel WJ; Rashba E; DeGroot PJ; Stromberg K; Shorofsky SR
    Heart Rhythm; 2008 Jan; 5(1):28-34. PubMed ID: 18053770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrillation Threshold Testing: Current Status.
    Hayase J; Do DH; Boyle NG
    Arrhythm Electrophysiol Rev; 2018 Dec; 7(4):288-293. PubMed ID: 30588318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-discharge defibrillation testing: Is it still justified?
    Kempa M; Królak T; Drelich Ł; Budrejko S; Daniłowicz-Szymanowicz L; Lewicka E; Kozłowski D; Raczak G
    Cardiol J; 2016; 23(5):532-538. PubMed ID: 27387062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts.
    Lambiase PD; Gold MR; Hood M; Boersma L; Theuns DAMJ; Burke MC; Weiss R; Russo AM; Kääb S; Knight BP
    Heart Rhythm; 2016 May; 13(5):1066-1074. PubMed ID: 26767422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?
    Frommeyer G; Zumhagen S; Dechering DG; Larbig R; Bettin M; Löher A; Köbe J; Reinke F; Eckardt L
    J Am Heart Assoc; 2016 Mar; 5(3):e003181. PubMed ID: 27068637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system.
    Strickberger SA; Hummel JD; Horwood LE; Jentzer J; Daoud E; Niebauer M; Bakr O; Man KC; Williamson BD; Kou W
    J Am Coll Cardiol; 1994 Oct; 24(4):1069-72. PubMed ID: 7930199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.
    Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R
    J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High defibrillation threshold with right-sided ICD implantation was resolved by a dual coil lead via persistent left superior vena cava.
    Fujito T; Nagahara D; Tsuzuki T; Kamiyama N; Mochizuki A; Miura T
    J Cardiol Cases; 2022 May; 25(5):262-265. PubMed ID: 35582083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
    Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of first-phase polarity of biphasic shocks on defibrillation threshold with a single transvenous lead system.
    Strickberger SA; Man KC; Daoud E; Neary MP; Horwood LE; Niebauer M; Hummel JD; Morady F
    J Am Coll Cardiol; 1995 Jun; 25(7):1605-8. PubMed ID: 7759712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead system optimization for transvenous defibrillation.
    Gold MR; Foster AH; Shorofsky SR
    Am J Cardiol; 1997 Nov; 80(9):1163-7. PubMed ID: 9359543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.